I agree that this site is using cookies. You can find further informations here.
X
Jonczyk, Agnieszka Walentyna
35  results:
Search for persons X
?
1

Intrauterine devices influence prostaglandin secretion by e..:

Piotrowska-Tomala, Katarzyna Karolina ; Jonczyk, Agnieszka Walentyna ; Szóstek-Mioduchowska, Anna...
BMC Veterinary Research.  20 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

The Role of Peroxisome Proliferator-Activated Receptors in ..:

Socha, Barbara Maria ; Łada, Piotr ; Jończyk, Agnieszka Walentyna..
Animals.  12 (2022)  12 - p. 1542 , 2022
Link: https://doi.org/10.3390/..
 
?
3

Effects of prostaglandin F2α (PGF2α) on cell-death pathways..:

Jonczyk, Agnieszka Walentyna ; Piotrowska-Tomala, Katarzyna Karolina ; Skarzynski, Dariusz Jan
BMC Veterinary Research.  15 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
4

Intrauterine devices influence prostaglandin secretion by e..:

Piotrowska-Tomala, Katarzyna Karolina ; Jonczyk, Agnieszka Walentyna ; Szostek-Mioduchowska, Anna...
10.1186/s12917-024-03889-0.  , 2024
Link: http://hdl.handle.net/10..
 
?
5

The Role of Peroxisome Proliferator-Activated Receptors in ..:

Barbara Maria Socha ; Piotr Łada ; Agnieszka Walentyna Jończyk..
Animal Genetics and Genomics.  , 2022
Link: https://doi.org/10.3390/..
 
?
6

The Role of Peroxisome Proliferator-Activated Receptors in ..:

Barbara Maria Socha ; Piotr Łada ; Agnieszka Walentyna Jończyk..
https://www.mdpi.com/2076-2615/12/12/1542.  , 2022
Link: https://doi.org/10.3390/..
 
?
7

Effects of prostaglandin F2α (PGF2α) on cell-death pathways..:

Agnieszka Walentyna Jonczyk ; Katarzyna Karolina Piotrowska-Tomala ; Dariusz Jan Skarzynski
http://link.springer.com/article/10.1186/s12917-019-2167-3.  , 2019
Link: https://doi.org/10.1186/..
 
?
8

Controlled Release of Encapsuled Stromal-Derived Factor 1α ..:

Bajdak-Rusinek, Karolina ; Fus-Kujawa, Agnieszka ; Jelonek, Katarzyna...
Bioengineering.  9 (2022)  12 - p. 754 , 2022
Link: https://doi.org/10.3390/..
 
?
9

Pre-Exposure Prophylaxis and Treatment with Tixagevimab/Cil..:

Frączkiewicz, Jowita ; Pawińska-Wąsikowska, Katarzyna ; Szymbor, Katarzyna...
Journal of Clinical Medicine.  13 (2024)  7 - p. 2029 , 2024
Link: https://doi.org/10.3390/..
 
?
10

Infections with Klebsiella pneumoniae in Children Undergoin..:

Sękowska, Alicja ; Czyżewski, Krzysztof ; Jaremek, Kamila...
Journal of Clinical Medicine.  13 (2024)  14 - p. 4078 , 2024
Link: https://doi.org/10.3390/..
 
?
11

Anti-PD-1 Therapy in Advanced Pediatric Malignancies in Nat..:

Marjańska, Agata ; Pawińska-Wąsikowska, Katarzyna ; Wieczorek, Aleksandra...
Cancers.  16 (2024)  5 - p. 968 , 2024
Link: https://doi.org/10.3390/..
 
?
12

Gemtuzumab ozogamicin for relapsed or primary refractory ac..:

Pawinska-Wasikowska, Katarzyna ; Czogala, Malgorzata ; Skoczen, Szymon...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
13

Dinutuximab Beta Maintenance Therapy in Patients with High-..:

Wieczorek, Aleksandra ; Żebrowska, Urszula ; Ussowicz, Marek...
Journal of Clinical Medicine.  12 (2023)  16 - p. 5252 , 2023
Link: https://doi.org/10.3390/..
 
?
14

Characteristics and treatment results of refractory and rel..:

Samborska, Magdalena ; Skalska-Sadowska, Jolanta ; Achkar, Robert...
Współczesna Onkologia.  27 (2023)  4 - p. 249-254 , 2023
Link: https://doi.org/10.5114/..
 
?
15

THE DIVERSITY OF PRESENTATION AND MANAGEMENT OF SUBCUTANEOU..:

Giza, Agnieszka ; Jedras, Justyna ; Rozploch, Maria...
Hematology, Transfusion and Cell Therapy.  44 (2022)  - p. S32 , 2022
Link: https://doi.org/10.1016/..
 
1-15